[1]陈香,赵军.PET-CT在非小细胞肺癌中的应用[J].国际放射医学核医学杂志,2005,29(3):97-100.
　CHEN Xiang,ZHAO Jun.The application value of PET-CT imaging in non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(3):97-100.
点击复制

PET-CT在非小细胞肺癌中的应用(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
29
期数:
2005年第3期
页码:
97-100
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The application value of PET-CT imaging in non-small cell lung cancer
作者:
陈香;  赵军
200233 上海, 复旦大学附属华山医院核医学科PET中心
Author(s):
CHEN Xiang;  ZHAO Jun
Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai 200233, China
关键词:
正电子体层显像; 计算机体层显像; 非小细胞肺癌; 18F-氟代脱氧葡萄糖
Keywords:
positron emission tomography; computed tomography; non-small cell lung cancer; 18F-fluorodeoxyglucose
分类号:
R817.4
摘要:
PET-CT实现了功能影像和结构影像的同机图像融合,诊断灵敏度及准确性好,对淋巴结分期准确,可以鉴别病灶的良恶性以及判断治疗后残存肿瘤的活力,使肺癌诊断的定性、定位、定量及定期更准确。本文综述PET-CT在非小细胞肺癌患者诊断和分期、疗效观察、治疗决策及放疗计划制订中的应用及存在的问题。
Abstract:
The recent development of an integrated PET-CT scanner for the simultaneous acquisition of anatomic(CT) and functional(PET) data in one device offers several advantages such as high sensitivity and accuracy of diagnosis. Its capability of accurate staging of lymph nodes, differentiation of lung lesions and evaluation of the tumor cell’s activity makes the determination of lung lesion’s characteristic, location, quantitation and staging more accurate. This article reviewed on the value and existing problems of PET-CT imaging in non-small cell lung cancer(NSCLC) for the diagnosis, staging, evaluation of therapeutic effects, determination of treatment strategy and the making of radiation treatment planning.

参考文献/References:

1 Herder GJM, Verboom P, Smit EF, et al. Practice, efficacy and cost of staging suspected non-small cell lung cancer:a retrospective study in two Dutch hospitals[J]. Thorax, 2002, 57(1):11-14.
2 Hany TF, Steinert HC, Goerres GW, et al. PET diagnostic accuracy:improvement with in-line PET-CT system:initial results[J]. Radiology, 2002, 225(2):575-581.
3 Cohade C, Osman M, Pannu HK, et al. Uptake in supraclavicular area fat("USA-Fat"):description on 18F-FDGPET-CT[J]. J Nucl Med,2003, 44(2):170-176.
4 Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron emission tomography and computed tomography[J]. N Engl J Med, 2003, 348(25):2500-2507.
5 Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer:dual-modality PET-CT in preoperative staging[J]. Radiology, 2003,229(2):526-533.
6 Marom EM, McAdams HP, Erasmus JJ, et al. Staging non-small cell lung cancer with whole-body PET[J]. Radiology, 1999, 212(3):803-809.
7 Keidar Z, Haim N, Guralnik L, et al. PET-CT using 18F-FDG in suspected lung cancer recurrence:diagnostic value and impact on patient management[J]. J Nucl Med, 2004, 45(10):1640-1646.
8 Caldwell CB, Mah K, Ung YC, et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small cell lung tumors on CT:the impact of 18FDG-hybrid PET fusion[J].Int J Radiat Oncol Biol Phys, 2001, 51(4):923-931.
9 Erdi YE, Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET)[J]. Radiother Oncol, 2002,62(1):51-60.
10 Ciernik, IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography(PET-CT):a feasibility study[J]. Int J Radiat Oncol Biol Phys,2003, 57(3):853-863.
11 Goerres GW, Kamel E, Seifert B, et al. Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET-CT system[J]. J Nucl Med, 2002,43(11):1469-1475.
12 Osman MM, Cohade C, Nakamoto Y, et al. Clinically significant inaccurate localization of lesions with PET-CT:frequency in 300patients[J]. J Nucl Med, 2003, 44(2):240-243.
13 Goerres GW, Kamel E, Heidelberg TN, et al. PET-CT image coregistration in the thorax:influence of respiration[J]. Eur J Nucl Med Mol Imaging, 2002, 29(3):351-60.
14 Beyer T, Blodgett T, Blodgett T, et al. Dual-modality PET-CT imaging:the effect of respiratory motion on eombinod image quality in clinical oncology[J]. Eur J Nucl Med Mol Imaging, 2003, 30(4):588-596.
15 Osman, MM, Cohade C, Nakamoto Y, et al. Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT[J]. Eur J Nucl Med Mol Imaging, 2003, 30(4):603-606.
16 Nehmeh SA, Erdi YE, Pan T, et al. Quantitation of respiratory motion during 4D-PET-CT acquisition[J]. Med Phys, 2004, 31(6):1333-1338.
17 Antoch G, Freudenberg LS, Beyer T, et al. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18FFDG PET-CT[J]. J Nucl Med, 2004, 45(1):56s-65s.
18 Nakamoto Y, Chin BB, Kraitchman DL, et al. Effects of nonionic intravenous contrast agents at PET-CT imaging:phantom and canine studies[J]. Radiology, 2003, 227(3):817-824.
19 Hara T, Kosaka N, Suzuki T, et al. Uptake rates of (18)F-fluorodeoxyglucose and (11)C-choline in lung cancer and pulmonary tuberculosis:a positron emission tomography study[J]. Chest, 2003,124(3):893-895.
20 Pieterman RM, Que TH, Elsinga PH. Comparison of (11)C-choline and(18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer[J]. J Nucl Med, 2002, 43(2):167-172.

备注/Memo

备注/Memo:
收稿日期:2004-11-21。
更新日期/Last Update: 1900-01-01